SOM230C

pasireotide · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SOM230C, covering 2014-05-16 to 2014-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Monthly SOM230C for Recurrent or Progressive Meningioma [Phase 2]